Takeshi Sugimoto Selected Research

Takeshi Sugimoto Research Topics

Disease

4	Atherosclerosis 01/2018 - 01/2018
4	Neoplasms (Cancer) 05/2013 - 10/2004
3	Hemorrhage 01/2019 - 10/2004
2	Lymphoma (Lymphomas) 04/2022 - 12/2016
2	Sick Sinus Syndrome 04/2022 - 02/2016
2	Insulin Resistance 01/2020 - 01/2020
1	Sarcopenia 06/2022
1	Bradycardia 04/2022
1	Communicable Diseases (Infectious Diseases) 03/2022
1	Acute Kidney Injury (Acute Renal Failure) 03/2022
1	Atrophic Muscular Disorders 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 11/2021
1	Hypersensitivity (Allergy) 11/2021
1	Fever (Fevers) 09/2021
1	Neutropenia 09/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2021
1	Infections 09/2021
1	Bacteremia 09/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2021
1	Cerebral Hemorrhage 01/2021
1	Pathologic Constriction (Stenosis) 03/2019
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 03/2019
1	Embolism (Embolus) 03/2019
1	Ischemia 03/2019
1	Pulmonary Tuberculosis 03/2019
1	Tuberculosis (Tuberculoses) 03/2019
1	Bone Marrow Failure Disorders 01/2019
1	Hemophilia A (Haemophilia) 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2018
1	Hemolysis 09/2017
1	Anemia 09/2017
1	Anorexia 12/2016
1	Nausea 12/2016
1	Vomiting 12/2016
1	Peripheral Arterial Disease 05/2016
1	Atrial Fibrillation 02/2016
1	Aortic Valve Disease 02/2016
1	Thrombosis (Thrombus) 02/2016
1	Infertility (Sterility) 01/2015
1	Diabetes Mellitus 01/2014
1	Carcinoma (Carcinomatosis) 05/2013
1	Transfusion-Related Acute Lung Injury 01/2013
1	Lupus Nephritis 01/2013
1	Virus Diseases (Viral Diseases) 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012
1	Otitis Media 12/2011

Drug/Important Bio-Agent (IBA)

4	SteroidsIBA 01/2019 - 01/2005
4	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2018 - 01/2013
2	Pharmaceutical PreparationsIBA 05/2013 - 01/2005
2	Heme (Haem)IBA 01/2013 - 11/2008
1	TriterpenesIBA 06/2022
1	Vancomycin FDA LinkGeneric 03/2022
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	Muscle Proteins (Muscle Protein)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Contractile ProteinsIBA 01/2022
1	Complement System Proteins (Complement)IBA 11/2021
1	Donath-Landsteiner antibodyIBA 11/2021
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 11/2021
1	R-CHOP protocolIBA 09/2021
1	ruxolitinibIBA 01/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2020
1	InflammasomesIBA 01/2020
1	Polyglycolic Acid (Polyglycolide)IBA 03/2019
1	Antitubercular AgentsIBA 03/2019
1	Nucleic AcidsIBA 03/2019
1	Prothrombin (Factor II)IBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 01/2019
1	Deoxyribonuclease I (Nickase)IBA 01/2018
1	LipidsIBA 01/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2017
1	Palonosetron (Aloxi)FDA Link 12/2016
1	AntiemeticsIBA 12/2016
1	AnticoagulantsIBA 02/2016
1	Ribosomal DNA (rDNA)IBA 01/2015
1	AlbuminsIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	PorphyrinsIBA 01/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2012
1	AutoantigensIBA 01/2012
1	Peroxidase (Myeloperoxidase)IBA 12/2011

Therapy/Procedure

8	Therapeutics 04/2022 - 01/2005
5	Drug Therapy (Chemotherapy) 04/2022 - 10/2005
3	Transplantation 01/2018 - 01/2018
2	Punctures 03/2019 - 05/2016
1	Vascular Closure Devices 03/2019
1	Catheters 03/2019
1	Percutaneous Coronary Intervention 03/2019
1	Homologous Transplantation 01/2018
1	VAP-cyclo protocol 12/2016
1	Intravenous Injections 12/2016
1	Maze Procedure 02/2016
1	Oral Administration 05/2013